Geftib 250mg Tablet

PRODUCT INTRODUCTION

Geftib 250mg Tablet is a medication primarily composed of Gefitinib, a targeted therapy drug used in the treatment of non-small cell lung cancer (NSCLC). It belongs to the class of medications known as tyrosine kinase inhibitors (TKIs). Geftib works by inhibiting the action of the epidermal growth factor receptor (EGFR), a protein that promotes the growth and spread of cancer cells. By blocking this protein, Geftib helps to slow down or stop the growth of cancer cells.

USES OF Geftib 250mg Tablet

Geftib 250mg Tablet is primarily prescribed for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It is specifically used in patients who have certain types of EGFR mutations, as determined by a healthcare provider through molecular testing. Geftib is usually recommended for patients whose cancer has not responded to other chemotherapy medications.

BENEFITS OF Geftib 250mg Tablet

• Geftib offers targeted therapy, meaning it specifically targets cancer cells with certain mutations while sparing healthy cells, resulting in potentially fewer side effects compared to traditional chemotherapy.
• It has been shown to improve progression-free survival (the length of time during and after the treatment that a patient lives with the disease without it getting worse) in patients with EGFR mutation-positive NSCLC.
• Geftib can help alleviate symptoms associated with advanced lung cancer, such as difficulty breathing, coughing, and chest pain, thereby enhancing the quality of life for patients.

SIDE EFFECTS OF Geftib 250mg Tablet

While Geftib is generally well-tolerated, it may cause some side effects. Common side effects may include:

• Skin rash or acne-like rash
• Diarrhea
• Fatigue
• Loss of appetite
• Nausea or vomiting
• Liver problems (elevated liver enzymes)
• Changes in the nails (such as brittleness or discoloration)